| 2NYY | A:1088-1293 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1 |
| 2NZ9 | B:1088-1293; B:1088-1293 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 |
| 2VU9 | A:1088-1293 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B |
| 2VUA | A:1088-1293 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN |
| 1S0B | A:1074-1289 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0 |
| 1S0C | A:1074-1289 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 |
| 1S0D | A:1074-1289 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 |
| 1S0E | A:1074-1289 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 |
| 1S0F | A:1074-1289 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0 |
| 1Z0H | B:1074-1289; B:1074-1289 | N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B |
| 2NM1 | A:1075-1290 | STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR |
| 2NP0 | A:1074-1289 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN |
| 3N7K | B:1089-1290; B:1089-1290 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN |
| 3R4S | B:1089-1291; B:1089-1291 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3R4U | B:1089-1291; B:1089-1291 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3N7J | A:1076-1276 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3OBR | A:1076-1276 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3OBT | A:1076-1276 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID |
| 3OGG | A:1076-1276 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D |
| 3RMX | D:1076-1276; D:1076-1276; D:1076-1276; D:1076-1276 | CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT |
| 3RMY | D:1076-1276; D:1076-1276; D:1076-1276; D:1076-1276 | CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT |
| 2VXR | A:1083-1297 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN |
| 3MPP | G:1083-1297 | BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN |
| 3PME | A:1080-1280 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE |
| 3N7L | A:1085-1284 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN |
| 3N7M | A:1085-1284 | CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 |
)
)